{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:01:05Z","timestamp":1771642865407,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":1422,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,15]]},"DOI":"10.1164\/rccm.202201-0018ed","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T18:22:31Z","timestamp":1644344551000},"page":"867-869","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":4,"title":["The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?"],"prefix":"10.1093","volume":"205","author":[{"given":"Giacomo","family":"Sgalla","sequence":"first","affiliation":[{"name":"Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies S.","family":"Wijsenbeek","sequence":"additional","affiliation":[{"name":"Centre for Interstitial Lung Diseases and Sarcoidosis, Erasmus University Medical Centre Rotterdam, Rotterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Richeldi","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"2026022021030151800_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"2026022021030151800_bib2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026022021030151800_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMp1500526","article-title":"Forced vital capacity in idiopathic pulmonary fibrosis\u2013FDA review of pirfenidone and nintedanib","volume":"372","author":"Karimi-Shah","year":"2015","journal-title":"N Engl J Med"},{"key":"2026022021030151800_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.201011-1790OC","article-title":"Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis","volume":"184","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022021030151800_bib5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1183\/09031936.00155108","article-title":"Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis","volume":"35","author":"Zappala","year":"2010","journal-title":"Eur Respir J"},{"key":"2026022021030151800_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/thoraxjnl-2011-201184","article-title":"Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis","volume":"67","author":"Richeldi","year":"2012","journal-title":"Thorax"},{"key":"2026022021030151800_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1164\/rccm.202109-2091OC","article-title":"Three-month FVC change: a trial endpoint for idiopathic pulmonary fibrosis based on individual participant data meta-analysis","volume":"205","author":"Khan","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022021030151800_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202006-2381CP","article-title":"Using Bayesian methods to augment the interpretation of critical care trials. An overview of theory and example reanalysis of the alveolar recruitment for acute respiratory distress syndrome trial","volume":"203","author":"Zampieri","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022021030151800_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.201511-2152OC","article-title":"Daily home spirometry: An effective tool for detecting progression in idiopathic pulmonary fibrosis","volume":"194","author":"Russell","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022021030151800_bib10","doi-asserted-by":"crossref","first-page":"2001518","DOI":"10.1183\/13993003.01518-2020","article-title":"Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial","volume":"58","author":"Noth","year":"2021","journal-title":"Eur Respir J"},{"key":"2026022021030151800_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026022021030151800_bib12","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1001\/jama.2018.6129","article-title":"Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: a randomized clinical trial","volume":"319","author":"Raghu","year":"2018","journal-title":"JAMA"},{"key":"2026022021030151800_bib13","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.202105-1193ST","article-title":"Patient-centered outcomes research in interstitial lung disease: an official American Thoracic Society research statement","volume":"204","author":"Aronson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026022021030151800_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/RTI.0000000000000220","article-title":"Automated quantitative computed tomography versus visual computed tomography scoring in idiopathic pulmonary fibrosis: validation against pulmonary function","volume":"31","author":"Jacob","year":"2016","journal-title":"J Thorac Imaging"},{"key":"2026022021030151800_bib15","doi-asserted-by":"crossref","first-page":"1601011","DOI":"10.1183\/13993003.01011-2016","article-title":"Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures","volume":"49","author":"Jacob","year":"2017","journal-title":"Eur Respir J"},{"key":"2026022021030151800_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.00071812","article-title":"Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis","volume":"43","author":"Maldonado","year":"2014","journal-title":"Eur Respir J"},{"key":"2026022021030151800_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"Lancet Respir Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/205\/8\/867\/67009937\/ajrccm_205_8_867.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/205\/8\/867\/67009937\/ajrccm_205_8_867.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:03:11Z","timestamp":1771639391000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/205\/8\/867\/8492080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,4,15]]},"published-print":{"date-parts":[[2022,4,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202201-0018ed","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"2022-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}